MARC details
| 000 -LEADER |
|---|
| fixed length control field |
05503nam a22004815i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
TR-AnTOB |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20231109085753.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
220524s2022 sz | s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9783030972363 |
| 024 7# - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.1007/978-3-030-97236-3 |
| Source of number or code |
doi |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
TR-AnTOB |
| Language of cataloging |
eng |
| Description conventions |
rda |
| Transcribing agency |
TR-AnTOB |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
İngilizce |
| 060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
WP 390 |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MFKC |
| Source |
bicssc |
|
|---|
| Subject category code |
HEA039060 |
| Source |
bisacsh |
|
|---|
| Subject category code |
MFKC |
| Source |
thema |
| 096 ## - LOCALLY ASSIGNED NLM-TYPE CALL NUMBER (OCLC) |
|---|
| Classification number |
WP390EBK |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Endometriosis and Adenomyosis |
| Medium |
[electronic resource] : |
| Remainder of title |
Global Perspectives Across the Lifespan / |
| Statement of responsibility, etc. |
edited by Engin Oral. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
1st ed. 2022. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Cham : |
| Name of producer, publisher, distributor, manufacturer |
Springer International Publishing : |
| -- |
Imprint: Springer, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2022. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 347 ## - DIGITAL FILE CHARACTERISTICS |
|---|
| File type |
text file |
| Encoding format |
PDF |
| Source |
rda |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Part I. Endometriosis: An Overview -- Endometriosis in Human History -- Global Epidemiologic Data on Endometriosis -- Presumptive Causes of Endometriosis across the Lifespan -- Pathogenesis of Endometriosis: Retrograde Menstruation and Metaplasia, Inflammation, Autoimmunity, Genetics -- Classification and Clinical Staging of Endometriosis -- Diagnostic Modalities: Imaging and Markers -- Multidisciplinary Aspects of Chronic Pain without Endometriosis -- Part II. Endometriosis across the Lifespan -- Endometriosis In Utero and Early Life -- Endometriosis in Adolescence -- Endometriosis in the Reproductive Years: Fertility and Pain -- Endometriosis in Peri- and Postmenopausal Years -- Pregnancy and Obstetric Outcomes -- Part III. Miscellaneous Clinical Presentations and Management of Endometriosis -- Recurrent Endometriosis -- A Rare Entity of Extra Pelvic Endometriosis: Scar, Diaphragmatic, Pulmonary Involvement -- Fertility Preservation for Endometriosis -- Malignancy Risks Associated with Endometriosis -- Psychological Considerations in Endometriosis -- Sexual Dysfunction and Endometriosis -- Nutritional Interventions, Complementary and Alternative Medicine for Endometriosis -- Prevention of Endometriosis: Is It Possible?- How to Establish a “Center of Excellence” for Endometriosis -- Cost Estimates Associated with Diagnosis and Treatment of Endometriosis -- Part IV. Adenomyosis: An Overview -- What Is Adenomyosis?- Adenomyosis in Medicine -- Insights into Adenomyosis Development -- Classification and Staging of Adenomyosis -- Non-invasive Diagnosis of Adenomyosis: Ultrasonography and MRI -- Part V: Adenomyosis across the Lifespan -- Adenomyosis in Adolescence -- Adenomyosis in the Reproductive Years: Abnormal Uterine Bleeding, Pain, Fertility -- Pregnancy and Obstetric Outcomes in Adenomyosis -- Does Adenomyosis Increase Cancer Risk?- Part VI. Clinical Pharmaceutical Features of Drugs Used in Endometriosis and Adenomyosis Treatment -- Hormonal Therapy: Oral Contraceptives, Progestins, Danazol, Aromatase Inhibitors -- GnRH Agonists and Antagonists -- Part VII. Guidelines and Future Prospects for Endometriosis and Adenomyosis -- Recent Guidelines on Endometriosis and Adenomyosis -- The Future of Endometriosis and Adenomyosis Research. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Although endometriosis and adenomyosis are often assessed under the same umbrella, the epidemiology, clinical manifestations and management strategies of endometriosis and adenomyosis occur differently during the life cycle of a woman. Endometriosis can be diagnosed at many points across the lifespan, including adolescence and the climacterium, as well as pregnancy. Being associated with potential adverse health effects, different clinical presentations requiring different therapeutic approaches render it imperative to tailor management strategies for each period of the lifespan: in utero and early life, puberty and adolescence, reproductive years, pregnancy, late reproductive age, and the menopause. This book provides comprehensive insight into the general aspects, diagnosis and treatment modalities of endometriosis and adenomyosis in all stages of a woman’s life - a unique element of its approach. Thematic sections discuss the basics of diagnosis and management of both endometriosis and adenomyosis from birth through menopause, including aspects of fertility preservation, sexual dysfunction, psychological considerations and prevention. The current pharmaceutical approaches and efficacy are presented, including progestins, aromatase inhibitors and GnRH agonists and antagonists. The final section provides current practice guidelines for the management of both conditions as well as an investigation into future research and clinical strategies. Taking a truly global perspective, Endometriosis and Adenomyosis will be a valuable resource for reproductive endocrinologists, infertility specialists and obstetricians and gynecologists worldwide. . |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Reproductive health. |
|
|---|
| Topical term or geographic name entry element |
Gynecology . |
|
|---|
| Topical term or geographic name entry element |
Reproductive Medicine. |
|
|---|
| Topical term or geographic name entry element |
Gynecology. |
| 653 #0 - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
Endometriosis |
|
|---|
| Uncontrolled term |
Adenomyosis |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Oral, Engin. |
| Relator term |
editor. |
| Relator code |
edt |
| -- |
http://id.loc.gov/vocabulary/relators/edt |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://doi.org/10.1007/978-3-030-97236-3">https://doi.org/10.1007/978-3-030-97236-3</a> |
| Materials specified |
Springer eBooks |
| Public note |
Online access link to the resource |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
National Library of Medicine |
| Koha item type |
E-Book |
